CalciMedica, Inc. Share Price & Technical Analysis
CALC · $0.65 (+3.17%)
Healthcare / Biotechnology
$0.65
+3.17%
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxic…
Price chart
Seasonality
May has 1 positive and 0 negative years (last 4 years shown)
0% return in May, 3% avg return in past 3 year May month.
-131% return in 2026, 76% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -87% | -44% | 0% | 0% | 0% | – | – | – | – | – | – | – | -131% |
| 25 | -26% | -12% | -17% | -20% | 6% | -6% | 113% | -21% | 11% | 0% | 43% | 53% | 125% |
| 24 | 155% | -38% | -7% | 36% | 0% | -29% | 21% | -7% | 7% | -16% | -8% | 0% | 115% |
| 23 | – | – | – | – | – | -17% | -15% | -14% | -13% | -12% | 91% | -31% | -11% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$9.46M
P/E ratio
—
52W high
$7.20
52W low
$0.46
Volume
22,814
Beta
1.03
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is CalciMedica, Inc. share price today?
- CalciMedica, Inc. (CALC) last traded around $0.65 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CALC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CALC. Download the app for real-time alerts.
- How can I analyze CalciMedica, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.